Triasima Portfolio Management Inc. Novo Nordisk A S Transaction History

Triasima Portfolio Management Inc.

$387 Million
Q3 2024

A detailed history of Triasima Portfolio Management Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Triasima Portfolio Management Inc. holds 32,974 shares of NVO stock, worth $2.8 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

32,974

Previous 62,772 47.47%

Holding current value

$2.8 Million

Previous $8.96 Million 56.18%

% of portfolio

1.02%

Previous 0.99%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$119.07 - $145.42 $3.55 Million - $4.33 Million	-29,798 Reduced 47.47%	32,974 $3.93 Million
Q2 2024 Aug 06, 2024	SELL	$122.71 - $146.91 $8,466 - $10,136	-69 Reduced 0.11%	62,772 $8.96 Million
Q1 2024 Apr 26, 2024	SELL	$102.11 - $135.92 $349,930 - $465,797	-3,427 Reduced 5.17%	62,841 $8.07 Million
Q4 2023 Jan 29, 2024	SELL	$87.78 - $105.45 $191,009 - $229,459	-2,176 Reduced 3.18%	66,268 $6.86 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $3.07 Million - $6.74 Million	33,768 Added 97.38%	68,444 $6.22 Million
Q2 2023 Aug 07, 2023	SELL	$155.98 - $172.65 $245,824 - $272,096	-1,576 Reduced 4.35%	34,676 $5.61 Million
Q1 2023 Apr 28, 2023	BUY	$132.34 - $159.14 $219,419 - $263,854	1,658 Added 4.79%	36,252 $5.77 Million
Q4 2022 Feb 09, 2023	BUY	$102.55 - $135.33 $3.55 Million - $4.68 Million	34,594 New	34,594 $4.68 Million
Q3 2022 Mar 10, 2023	SELL	$95.28 - $116.93 $1.32 Million - $1.62 Million	-13,885 Reduced 27.26%	37,043 $3.69 Million
Q2 2022 Mar 10, 2023	SELL	$103.24 - $121.81 $111,499 - $131,554	-1,080 Reduced 2.08%	50,928 $5.68 Million
Q1 2022 Mar 10, 2023	BUY	$93.1 - $112.54 $1.62 Million - $1.96 Million	17,414 Added 50.34%	52,008 $5.78 Million
Q4 2021 Mar 10, 2023	BUY	$95.88 - $117.08 $382,561 - $467,149	3,990 Added 8.05%	53,538 $6 Million
Q3 2021 Mar 10, 2023	BUY	$84.42 - $106.62 $899,748 - $1.14 Million	10,658 Added 27.41%	49,548 $4.76 Million
Q2 2021 Mar 10, 2023	BUY	$67.66 - $84.76 $1.19 Million - $1.49 Million	17,600 Added 82.67%	38,890 $3.26 Million
Q1 2021 Mar 10, 2023	BUY	$67.06 - $75.82 $502,950 - $568,650	7,500 Added 54.39%	21,290 $1.44 Million
Q4 2020 Mar 10, 2023	SELL	$63.89 - $73.8 $1.33 Million - $1.54 Million	-20,804 Reduced 60.14%	13,790 $963,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Triasima Portfolio Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Triasima Portfolio Management Inc. with notifications on news.

Account

Triasima Portfolio Management Inc. Novo Nordisk A S Transaction History